NCT05137067

A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents.

Effectiveness of RaproCell in Alleviating the Side Effects of Chemotherapeutic Agents, Without Adversely Impacting the Overall Success of the Agents on Cancer Cells.

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 90 (actual)
• Sponsor: Optimal Health Research · Academic / Other
• Sex: All
• Age: 25 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study will assess the effectiveness of a natural nutraceutical in treating the known side effects of chemotherapeutic agents in cancer patients.

Detailed description

This study will assess the effectiveness of a natural nutraceutical in treating the known side effects of chemotherapeutic agents in cancer patients. The study will be observing the standard treatment protocol for any degradation or enhancement due to the nutraceutical.

Conditions

• Breast Cancer
• Lung Cancer
• Prostate Cancer

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Chemotherapeutic agent A(Docetaxel),B(Cisplatin) or C(Docetaxel) plus Dietary Supplement (RaproCell)	Chemotherapeutic side effect elimination without adversely effecting the Chemotherapeutic agent drug.
DRUG	Chemotherapeutic agent A(Docetaxel),B(Cisplatin) or C(Docetaxel) plus placebo	Placebo
DRUG	Chemotherapeutic agent A(Docetaxel),B(Cisplatin) or C(Docetaxel).	Chemotherapeutic agent A(Docetaxel),B(Cisplatin) or C(Docetaxel).

Timeline

• Start date: 2021-01-20
• Primary completion: 2022-10-18
• Completion: 2023-05-25
• First posted: 2021-11-30
• Last updated: 2025-03-21

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study